New prescription product for smoking cessation called Zyban (bupropion)

    Glaxo is getting ready to launch a new prescription product for smoking cessation called Zyban (bupropion).

    It'll be out soon in the U.S...possibly next year in Canada.

    Zyban will be the first non-nicotine drug for smoking cessation. It reduces some withdrawal symptoms and decreases the urge to smoke.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote